Robert Chess, Director at Twist Bioscience Corp (TWST), sold 10,000 shares at $47.00 ($470K) on 2026-03-17, disclosed to the SEC on 2026-03-19.
Scheduled sale ($470k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| TWST | SELL | 2025-02-11 | $312K | — | Filing → |
| TWST | SELL | 2025-01-10 | $250K | — | Filing → |
| TWST | SELL | 2024-12-30 | $326K | — | Filing → |